BridgeBio Pharma, Inc.
BBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$183 | -$184 | -$170 | -$267 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $37 | $26 | $30 |
| Change in WC | -$4 | $19 | -$116 | $13 |
| Other Non-Cash | $76 | $45 | $59 | $28 |
| Operating Cash Flow | -$110 | -$81 | -$199 | -$195 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$1 | -$2 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3 | -$8 | $0 | $0 |
| Inv. Sales/Matur. | $8 | $0 | $0 | $0 |
| Other Inv. Act. | $2 | -$5 | $0 | -$3 |
| Investing Cash Flow | $4 | -$13 | -$2 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6 | $300 | $116 | $500 |
| Stock Issued | $8 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$2 | -$50 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | $4 | -$6 | -$25 |
| Financing Cash Flow | -$1 | $302 | $60 | $474 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$106 | $208 | -$141 | $275 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $749 | $543 | $683 | $408 |
| End Cash | $643 | $751 | $543 | $683 |
| Free Cash Flow | -$110 | -$86 | -$201 | -$199 |